Novo Holdings A/S Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$1.6T
Holdings
27
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VTIVANGUARD INDEX FDS | 1,038,550 | $340.8B | 21.97% | |
| 2 | BNBROOKFIELD CORP | 2,330,830 | $159.8B | 10.30% | |
| 3 | ASMLASML HOLDING N V | 145,836 | $141.2B | 9.10% | |
| 4 | MIRMMIRUM PHARMACEUTICALS INC | 1,264,028 | $92.7B | 5.97% | |
| 5 | EWTXEDGEWISE THERAPEUTICS INC | 5,350,000 | $86.8B | 5.59% | |
| 6 | CRMSALESFORCE INC | 330,187 | $78.3B | 5.04% | |
| 7 | MRUSMERUS N V | 750,000 | $70.6B | 4.55% | |
| 8 | CRNXCRINETICS PHARMACEUTICALS IN | 1,625,000 | $67.7B | 4.36% | |
| 9 | VRDNVIRIDIAN THERAPEUTICS INC | 2,380,000 | $51.4B | 3.31% | |
| 10 | BABAALIBABA GROUP HLDG LTD | 257,327 | $46.0B | 2.96% | |
| 11 | ZBIOZENAS BIOPHARMA INC | 2,000,000 | $44.4B | 2.86% | |
| 12 | PHVSPHARVARIS N V | 1,750,000 | $43.7B | 2.81% | |
| 13 | RXRXRECURSION PHARMACEUTICALS IN | 7,929,835 | $38.7B | 2.49% | |
| 14 | AVBPARRIVENT BIOPHARMA INC | 1,942,142 | $35.8B | 2.31% | |
| 15 | BMRNBIOMARIN PHARMACEUTICAL INC | 660,000 | $35.7B | 2.30% | |
| 16 | PCVXVAXCYTE INC | 916,160 | $33.0B | 2.13% | |
| 17 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,200,000 | $31.0B | 2.00% | |
| 18 | ELVNENLIVEN THERAPEUTICS INC | 1,426,260 | $29.2B | 1.88% | |
| 19 | IM8NINSMED INC | 200,000 | $28.8B | 1.86% | |
| 20 | VALNVALNEVA SE | 2,345,000 | $28.6B | 1.84% | |
| 21 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 1,961,317 | $22.7B | 1.46% | |
| 22 | APGEAPOGEE THERAPEUTICS INC | 500,000 | $19.9B | 1.28% | |
| 23 | FDMT4D MOLECULAR THERAPEUTICS IN | 2,000,000 | $17.4B | 1.12% | |
| 24 | LNZALANZATECH GLOBAL INC | 158,148 | $3.9B | 0.25% | |
| 25 | MQMARQETA INC | 441,558 | $2.3B | 0.15% | |
| 26 | IOBTIO BIOTECH INC | 2,512,453 | $912.3M | 0.06% | |
| 27 | GLTOGALECTO INC | 86,579 | $322.1M | 0.02% |